Key statistics
As of last trade AxoGen Inc (LT3:FRA) traded at 26.00, -15.03% below its 52-week high of 30.60, set on Jan 27, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 26.00 |
|---|---|
| High | 26.00 |
| Low | 26.00 |
| Bid | 25.60 |
| Offer | 26.20 |
| Previous close | 26.20 |
| Average volume | 24.43 |
|---|---|
| Shares outstanding | 51.90m |
| Free float | 49.55m |
| P/E (TTM) | -- |
| Market cap | 1.65bn USD |
| EPS (TTM) | -0.3413 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:20 GMT.
More ▼
Announcements
- Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
- Axogen Announces Proposed Public Offering of Common Stock
- Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
- Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
- Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen, Inc. Reports Third Quarter 2025 Financial Results
More ▼
